These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 1664185)
1. AICAriboside inhibits gluconeogenesis in isolated rat hepatocytes. Vincent MF; Marangos P; Gruber HE; Van den Berghe G Adv Exp Med Biol; 1991; 309B():359-62. PubMed ID: 1664185 [No Abstract] [Full Text] [Related]
2. Inhibition of glycolysis by 5-amino-4-imidazolecarboxamide riboside in isolated rat hepatocytes. Vincent MF; Bontemps F; Van den Berghe G Biochem J; 1992 Jan; 281 ( Pt 1)(Pt 1):267-72. PubMed ID: 1531010 [TBL] [Abstract][Full Text] [Related]
3. Inhibition by AICA riboside of gluconeogenesis in isolated rat hepatocytes. Vincent MF; Marangos PJ; Gruber HE; Van den Berghe G Diabetes; 1991 Oct; 40(10):1259-66. PubMed ID: 1657665 [TBL] [Abstract][Full Text] [Related]
4. Hypoglycaemic effect of AICAriboside in mice. Vincent MF; Erion MD; Gruber HE; Van den Berghe G Diabetologia; 1996 Oct; 39(10):1148-55. PubMed ID: 8897001 [TBL] [Abstract][Full Text] [Related]
5. Inhibition of fructose-1,6-bisphosphatase by aminoimidazole carboxamide ribotide prevents growth of Salmonella enterica purH mutants on glycerol. Dougherty MJ; Boyd JM; Downs DM J Biol Chem; 2006 Nov; 281(45):33892-9. PubMed ID: 16987812 [TBL] [Abstract][Full Text] [Related]
6. Inhibition of fatty acid and cholesterol synthesis by stimulation of AMP-activated protein kinase. Henin N; Vincent MF; Gruber HE; Van den Berghe G FASEB J; 1995 Apr; 9(7):541-6. PubMed ID: 7737463 [TBL] [Abstract][Full Text] [Related]
7. Substrate cycling between 5-amino-4-imidazolecarboxamide riboside and its monophosphate in isolated rat hepatocytes. Vincent MF; Bontemps F; Van den Berghe G Biochem Pharmacol; 1996 Oct; 52(7):999-1006. PubMed ID: 8831718 [TBL] [Abstract][Full Text] [Related]
8. Cell-type specificity of inhibition of glycolysis by 5-amino-4-imidazolecarboxamide riboside. Lack of effect in rabbit cardiomyocytes and human erythrocytes, and inhibition in FTO-2B rat hepatoma cells. Javaux F; Vincent MF; Wagner DR; van den Berghe G Biochem J; 1995 Feb; 305 ( Pt 3)(Pt 3):913-9. PubMed ID: 7848293 [TBL] [Abstract][Full Text] [Related]
9. AMPK or ZMPK? Shakulov RS Med Hypotheses; 2006; 67(3):670. PubMed ID: 16762515 [No Abstract] [Full Text] [Related]
10. Application of (13)C-filtered (1)H NMR to evaluate drug action on gluconeogenesis and glycogenolysis simultaneously in isolated rat hepatocytes. Hansen SH; McCormack JG NMR Biomed; 2002 Aug; 15(5):313-9. PubMed ID: 12203222 [TBL] [Abstract][Full Text] [Related]
11. Z-nucleotides formation in human and rat cells. Gruber HE; Jimenez R; Barankiewicz J Adv Exp Med Biol; 1991; 309B():363-6. PubMed ID: 1781398 [No Abstract] [Full Text] [Related]
12. Influence of succinylpurines on the binding of adenosine to a particulate fraction of rat cerebral cortex. Vincent MF; Van den Berghe G Adv Exp Med Biol; 1989; 253B():441-5. PubMed ID: 2610130 [No Abstract] [Full Text] [Related]
13. Effect of 5-amino-4-imidazolecarboxamide riboside on renal ammoniagenesis. Study with [15N]aspartate. Nissim I; Yudkoff M; Segal S J Biol Chem; 1986 May; 261(14):6509-14. PubMed ID: 2871025 [TBL] [Abstract][Full Text] [Related]
14. Metformin reduces liver glucose production by inhibition of fructose-1-6-bisphosphatase. Hunter RW; Hughey CC; Lantier L; Sundelin EI; Peggie M; Zeqiraj E; Sicheri F; Jessen N; Wasserman DH; Sakamoto K Nat Med; 2018 Sep; 24(9):1395-1406. PubMed ID: 30150719 [TBL] [Abstract][Full Text] [Related]
15. Glycogen-dependent effects of 5-aminoimidazole-4-carboxamide (AICA)-riboside on AMP-activated protein kinase and glycogen synthase activities in rat skeletal muscle. Wojtaszewski JF; Jørgensen SB; Hellsten Y; Hardie DG; Richter EA Diabetes; 2002 Feb; 51(2):284-92. PubMed ID: 11812734 [TBL] [Abstract][Full Text] [Related]
16. [Effect of AICAriboside on the protection of the ischemic myocardium and its mechanism of action]. Shi AY Sheng Li Ke Xue Jin Zhan; 1985 Apr; 16(2):171-3. PubMed ID: 4012259 [No Abstract] [Full Text] [Related]
17. Protection against injury during ischemia and reperfusion by acadesine derivatives GP-1-468 and GP-1-668. Studies in the transplanted rat heart. Galiñanes M; Zhai X; Bullough D; Mullane KM; Hearse DJ J Thorac Cardiovasc Surg; 1995 Sep; 110(3):752-61. PubMed ID: 7564443 [TBL] [Abstract][Full Text] [Related]
18. 5-Aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside and metformin inhibit hepatic glucose phosphorylation by an AMP-activated protein kinase-independent effect on glucokinase translocation. Guigas B; Bertrand L; Taleux N; Foretz M; Wiernsperger N; Vertommen D; Andreelli F; Viollet B; Hue L Diabetes; 2006 Apr; 55(4):865-74. PubMed ID: 16567505 [TBL] [Abstract][Full Text] [Related]
19. 5-Aminoimidazole-4-carboxamide riboside induces apoptosis in Jurkat cells, but the AMP-activated protein kinase is not involved. López JM; Santidrián AF; Campàs C; Gil J Biochem J; 2003 Mar; 370(Pt 3):1027-32. PubMed ID: 12452797 [TBL] [Abstract][Full Text] [Related]
20. Regulation of adenosine concentrations by acadesine (AICA-riboside) in human B-lymphoblasts. Barankiewicz J; Jimenez R; Uyesaka J; Gruber HE Adv Exp Med Biol; 1991; 309A():275-8. PubMed ID: 1789225 [No Abstract] [Full Text] [Related] [Next] [New Search]